New drug tested to fight severe anemia after Life-Saving leukemia transplant
NCT ID NCT07362095
Summary
This study is testing if a drug called luspatercept is safe and can help treat anemia (low red blood cells) in people who have had a stem cell transplant for acute leukemia. The main goal is to see if the drug can increase hemoglobin levels enough to reduce the need for blood transfusions. Researchers will give the drug as two injections after the transplant and monitor patients closely for 8 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhujiang Hospital
RECRUITINGGuangzhou, Guangdong, China
Contact
Conditions
Explore the condition pages connected to this study.